Global private equity and venture capital news and research

Denmark’s Novo leads $30m round for Elevation Pharmaceuticals

4 Jan 2012

nebuliser-mask_sqElevation Pharmaceuticals has closed a $30m Series B financing round led by new investor Novo Ventures, which will fund the development of the company’s new aerosol therapy for patients living with chronic obstructive pulmonary disease (COPD).

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016